As thankfully noted by Dan Dyar ( http://www.parameterz.com ) this paper has an error in the Table 2 .

Unfortunately a mistake occurred to the authors during the final layout step in the Table 2 . When finalizing this Table obviously the last column (RVESa z-scores) was incidentally deleted and the column next to the last was named “RVESa z-score”. The proper heading of the last column in the original manuscript should be “RVESL z-score/male” and the heading of the columns next to the last should be “RVESL z-score/female”. Furthermore an additional column should be added (RVESa z-scores).

The corrected Table 2 can now found uploaded with this erratum. The authors thank Dan Dyar for his relevant hint and apologize for this error.

Table 2

Age related z-scores for RVEDb-d, RVEDm-d, RVEDL, RVESL, RVEDa, and RVESa are shown

		RVEDb-d z-score			RVEDm-d z-score			RVEDL z-score			RVEDa z-score			RVESL z-score						RVESa z-score
														female			male
		−2	0	2	−2	0	2	−2	0	2	−2	0	2	−2	0	2	−2	0	2	−2	0	2
month	1	1.0	1.4	2.0	0.9	1.2	1.7	1.2	2.3	3.3	1.0	2.6	4.9	1.3	1.7	2.4	1.3	1.8	2.5	0.9	1.7	3.1
	2	1.0	1.4	2.0	0.9	1.3	1.8	1.4	2.4	3.5	1.2	2.9	5.4	1.3	1.8	2.5	1.3	1.8	2.6	1.0	1.8	3.3
	3	1.1	1.5	2.1	0.9	1.3	1.9	1.5	2.5	3.6	1.4	3.2	5.7	1.3	1.9	2.6	1.4	1.9	2.6	1.0	1.9	3.5
	4-6	1.1	1.5	2.2	1.0	1.4	1.9	1.6	2.7	3.8	1.6	3.6	6.3	1.4	1.9	2.7	1.4	2.0	2.7	1.1	2.1	3.8
	7-12	1.2	1.6	2.3	1.0	1.4	2.0	1.9	3.0	4.1	2.1	4.3	7.3	1.5	2.1	2.8	1.5	2.1	2.9	1.3	2.3	4.3
year	2	1.3	1.8	2.5	1.1	1.6	2.2	2.3	3.4	4.5	2.8	5.4	8.8	1.7	2.3	3.1	1.7	2.3	3.2	1.6	2.8	5.0
	3	1.4	2.0	2.7	1.2	1.7	2.4	2.6	3.8	4.9	3.7	6.6	10.4	1.8	2.5	3.4	1.9	2.6	3.6	1.9	3.4	6.0
	4	1.5	2.1	2.9	1.3	1.9	2.6	2.9	4.1	5.3	4.5	7.7	11.8	2.0	2.7	3.7	2.1	2.8	3.8	2.2	3.9	6.9
	5	1.6	2.2	3.1	1.4	2.0	2.8	3.2	4.4	5.6	5.2	8.7	13.1	2.1	2.9	4.0	2.2	3.0	4.1	2.5	4.4	7.7
	6	1.7	2.4	3.3	1.5	2.1	2.9	3.4	4.6	5.8	5.9	9.7	14.3	2.3	3.1	4.2	2.4	3.2	4.4	2.8	4.9	8.6
	7	1.8	2.5	3.4	1.6	2.2	3.0	3.6	4.8	6.1	6.6	10.6	15.5	2.4	3.3	4.4	2.5	3.4	4.6	3.2	5.5	9.5
	8	1.9	2.6	3.6	1.7	2.3	3.2	3.8	5.0	6.3	7.2	11.4	16.6	2.5	3.4	4.7	2.7	3.6	4.8	3.5	6.0	10.3
	9	2.0	2.7	3.7	1.7	2.4	3.3	4.0	5.2	6.5	7.9	12.3	17.7	2.6	3.6	4.9	2.8	3.8	5.1	3.8	6.6	11.2
	10	2.1	2.8	3.9	1.8	2.5	3.5	4.1	5.4	6.7	8.5	13.1	18.8	2.8	3.8	5.1	2.9	3.9	5.3	4.2	7.2	12.2
	11	2.1	2.9	4.0	1.9	2.6	3.6	4.3	5.6	6.9	9.1	13.9	19.8	2.9	3.9	5.3	3.1	4.1	5.5	4.6	7.7	13.1
	12	2.2	3.1	4.2	2.0	2.7	3.7	4.5	5.8	7.1	9.7	14.7	20.8	3.0	4.1	5.5	3.2	4.3	5.8	5.0	8.4	14.1
	13	2.3	3.2	4.3	2.1	2.8	3.9	4.6	5.9	7.2	10.4	15.5	21.8	3.1	4.2	5.8	3.4	4.5	6.0	5.4	9.0	15.1
	14	2.4	3.3	4.5	2.1	2.9	4.0	4.7	6.1	7.4	11.0	16.3	22.7	3.2	4.4	6.0	3.5	4.6	6.2	5.8	9.6	16.1
	15	2.5	3.4	4.6	2.2	3.0	4.1	4.9	6.2	7.6	11.6	17.1	23.7	3.4	4.6	6.2	3.6	4.8	6.4	6.2	10.3	17.2
	16	2.6	3.5	4.8	2.3	3.1	4.2	5.0	6.4	7.7	12.1	17.8	24.6	3.5	4.7	6.4	3.8	5.0	6.7	6.6	11.0	18.2
	17	2.7	3.6	4.9	2.4	3.2	4.4	5.1	6.5	7.9	12.7	18.6	25.5	3.6	4.9	6.6	3.9	5.2	6.9	7.1	11.7	19.3
	18	2.7	3.7	5.1	2.4	3.3	4.5	5.3	6.6	8.0	13.3	19.3	26.4	3.7	5.0	6.8	4.1	5.4	7.1	7.6	12.4	20.5

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

1. Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study)
2. Effect of Permanent Atrial Fibrillation on Cognitive Function in Patients With Chronic Heart Failure
3. Prognostic Utility of Brain Natriuretic Peptide in Asymptomatic Patients With Significant Mitral Regurgitation and Preserved Left Ventricular Ejection Fraction
4. Anti-Inflammatory Role of Statins in Preventing Postoperative Atrial Fibrillation

Stay updated, free articles. Join our Telegram channel

Join